Area riservata



Ipersensibilità allergica

New genital herpes vaccine candidate provides powerful protection in preclinical tests
AllergologiaApproximately 500 million people around the world are infected with the genital herpes virus known as herpes simplex virus 2 (HSV2).
Fonte: Immune System/Vaccines News From Medical News Today
 

Aggiungi commento


Codice di sicurezza
Aggiorna